Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Group",
"id" : "179783",
"meta" : {
"versionId" : "3",
"lastUpdated" : "2023-12-04T20:29:22.185Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-definition"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Group 179783</b></p><a name=\"179783\"> </a><a name=\"hc179783\"> </a><a name=\"179783-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 3; Last updated: 2023-12-04 20:29:22+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-exposure-definition.html\">ExposureDefinition</a></p></div><p><b>Artifact related artifact</b>: No display for RelatedArtifact (type: cite-as; citation: Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783.)</p><p><b>Artifact Author</b>: Brian S. Alper: </p><p><b>url</b>: <a href=\"https://fevir.net/resources/Group/179783\">https://fevir.net/resources/Group/179783</a></p><p><b>identifier</b>: FEvIR Object Identifier/179783</p><p><b>name</b>: Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days</p><p><b>title</b>: Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p>\n</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>membership</b>: Conceptual</p><h3>Characteristics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td><td><b>Description</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:\">Defined by Reference</span></td><td><a href=\"ActivityDefinition-213.html\">IV remdesivir 200 mg then 100 mg/day for 9 days</a></td><td>false</td><td><div><p>Remdesivir IV 200 mg once then 100 mg once daily for 9 days</p>\n</div></td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact",
"valueRelatedArtifact" : {
"type" : "cite-as",
"citation" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179783. Revised 2023-11-30. Available at: https://fevir.net/resources/Group/179783. Computable resource at: https://fevir.net/resources/Group/179783."
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
"valueContactDetail" : {
"name" : "Brian S. Alper"
}
}
],
"url" : "https://fevir.net/resources/Group/179783",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "179783",
"assigner" : {
"display" : "Computable Publishing LLC"
}
}
],
"name" : "Remdesivir_IV_200_mg_once_then_100_mg_once_daily_for_9_days",
"title" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days",
"status" : "active",
"publisher" : "Computable Publishing LLC",
"contact" : [
{
"telecom" : [
{
"system" : "email",
"value" : "support@computablepublishing.com"
}
]
}
],
"description" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days",
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"membership" : "conceptual",
"characteristic" : [
{
"code" : {
"text" : "Defined by Reference"
},
"valueReference" : {
🔗 "reference" : "ActivityDefinition/213",
"type" : "ActivityDefinition",
"display" : "IV remdesivir 200 mg then 100 mg/day for 9 days"
},
"exclude" : false,
"description" : "Remdesivir IV 200 mg once then 100 mg once daily for 9 days"
}
]
}